Table 1.

Characteristics of the patients in the training and validation cohorts

		Training cohort (n=107)			Validation cohort (n=45)
		Grade II	Grade III	Grade IV	Grade II	Grade III	Grade IV
n		36	28	43	11	11	23
Age (years), mean±SD		44.38±11.31	48.04±12.02	54.46±12.58	40.18±8.85	56.73±10.98	56.83±13.07
NLR, median (Q1, Q3)		2.07 (1.72, 3.22)	2.44 (1.84, 3.51)	2.83 (2.07, 5.14)	1.83 (1.48, 2.9)	3.42 (2.56, 4.4)	3.00 (2.30, 5.4)
RDW, mean±SD		13.1±1.04	13.34±1.05	13.37±1.52	13.21±1.38	12.87±0.58	13.42±0.86
Ki-67 LI, n	≤10%	42			14
	>10%	65			31

SD, standard deviation; NLR, neutrophil-lymphocyte ratio; Q1–Q3, 25^th and 75^th percentiles; RDW, red cell distribution width; Ki-67 LI, Ki-67 labeling index.